(Q47929225)

English

Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c-erbb-2) status in urothelial carcinoma

scientific article published on 17 March 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c-erbb-2) status in urothelial carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

immunohistochemistry

1 reference

based on heuristic

inferred from title

Anne Vincent-Salomon

3

object named as

Anne Vincent-Salomon

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Philippe Beuzeboc

6

object named as

Philippe Beuzeboc

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

author name string

Gonzague de Pinieux

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Delphine Colin

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Jérôme Couturier

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Delphine Amsellem-Ouazana

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Annick Vieillefond

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

publication date

17 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

444

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

415-419

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunocytochemical localization of c-erbB-2 protein in transitional cell carcinoma of the urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder*1

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical analysis of c-erbB-2 oncogene product and epidermal growth factor receptor expression in human urinary bladder carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-myc, c-erbB-1 and c-erbB-2 expressions in urothelial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of c-erbB-2 protein product in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized, high-grade transitional cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Immunohistochemically Demonstrated c-erb B-2 Oncoprotein Expression as a Prognostic Factor in Transitional Cell Carcinoma of the Urinary Bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2--a possible target for therapy of metastatic urinary bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of erbB-2 gene amplification in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of c-erbB-2 gene product in urinary bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15029496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-004-0986-4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

release_q2lggw7rkbgkbithqa3yymdpim

1 reference

https://api.fatcat.wiki/v0/release/q2lggw7rkbgkbithqa3yymdpim

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15029496

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47929225&oldid=2208955070"